About
This clinical tool helps healthcare professionals predict the risk of developing CA-AKI. It provides a risk score based on user input, but emphasizes that clinical judgment should always guide patient care and that calculations require re-checking.
What's New in RenalGuard® AKI Calculator
1.0.2
October 27, 2025
- Minor calculations fixed
User reviews
FAQ
What is RenalGuard AKI Calculator used for?
RenalGuard AKI Calculator is a clinical tool designed for healthcare professionals to predict the risk of developing CA-AKI (Cardiorenal Acute Kidney Injury). It helps in assessing potential risks based on specific patient data.
Is RenalGuard AKI Calculator free to use?
Yes, RenalGuard AKI Calculator is available for free. There are no in-app purchases or subscription fees associated with its use.
Who should use RenalGuard AKI Calculator?
This tool is intended for use by physicians and other healthcare professionals. It is designed to assist them in their clinical judgment regarding patient care.
Does RenalGuard AKI Calculator provide medical advice?
No, RenalGuard AKI Calculator contains medical information but is not a substitute for professional medical advice. Users should always consult a physician for health concerns.
On what devices can I use RenalGuard AKI Calculator?
RenalGuard AKI Calculator is supported on iPhone, iPad, and iPod devices. It is designed for mobile use by healthcare professionals.
How often is RenalGuard AKI Calculator updated?
The latest version of RenalGuard AKI Calculator is 1.0.2, and it was last updated on October 27, 2025. This indicates regular maintenance and potential updates.
What is the age rating for RenalGuard AKI Calculator?
RenalGuard AKI Calculator has an age rating of 17+. This suggests it contains content or is intended for an audience that requires a certain level of maturity.
Can I rely solely on RenalGuard AKI Calculator for patient care decisions?
No, the app explicitly states that calculations must be re-checked and should not be used alone to guide patient care. Clinical judgment remains paramount.






